文章

Ruck, T., Bittner, S., Simon, O. J., Gobel, K., Wiendl, H., Schilling, M., & Meuth, S. G. (2013). Long-term effects of dalfampridine in patients with multiple sclerosis. Journal of the neurological sciences.

被如下文章引用：

• TITLE: Powerful Efficacy of GCSB-5 Treatment for Improving Fatigue and Motor Function in Multiple Sclerosis (MS): A Randomized Double Blind, Place-bo-Controlled Study
• AUTHORS: Ji Yun Shin
• KEYWORDS: Multiple Sclerosis, GCSB-5 Treatment
• JOURNAL NAME: Open Access Library PrePrints DOI: 10.4236/oalib.preprints.1200150 Sep 27, 2016
• ABSTRACT: Multiple Sclerosis (MS) is the most common disability in young adults that requires early symptomatic treatment to prevent long-term disability. Among young adults, MS is the most common central nerv-ous system (CNS) chronic inflammatory illness that is characterized by demyelination in the CNS. However, current disease-modifying treatments are not sufficiently effective for preventing the variety of symptoms during the course of disease.